chr3-184242883-C-T

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 1P and 9B. PP2BP4_StrongBS1_SupportingBS2

The NM_005787.6(ALG3):​c.1084G>A​(p.Val362Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0014 in 1,613,810 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V362G) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00079 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0015 ( 3 hom. )

Consequence

ALG3
NM_005787.6 missense

Scores

2
7
10

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:5B:1

Conservation

PhyloP100: 7.73

Publications

8 publications found
Variant links:
Genes affected
ALG3 (HGNC:23056): (ALG3 alpha-1,3- mannosyltransferase) This gene encodes a member of the ALG3 family. The encoded protein catalyses the addition of the first dol-P-Man derived mannose in an alpha 1,3 linkage to Man5GlcNAc2-PP-Dol. Defects in this gene have been associated with congenital disorder of glycosylation type Id (CDG-Id) characterized by abnormal N-glycosylation. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2008]
ALG3 Gene-Disease associations (from GenCC):
  • ALG3-congenital disorder of glycosylation
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, ClinGen, PanelApp Australia, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 16 curated pathogenic missense variants (we use a threshold of 10). The gene has 5 curated benign missense variants. Gene score misZ: -0.31675 (below the threshold of 3.09). Trascript score misZ: 0.74965 (below the threshold of 3.09). GenCC associations: The gene is linked to ALG3-congenital disorder of glycosylation.
BP4
Computational evidence support a benign effect (MetaRNN=0.020545602).
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.000795 (121/152284) while in subpopulation EAS AF = 0.00559 (29/5190). AF 95% confidence interval is 0.004. There are 0 homozygotes in GnomAd4. There are 53 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAdExome4 at 3 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ALG3NM_005787.6 linkc.1084G>A p.Val362Ile missense_variant Exon 8 of 9 ENST00000397676.8 NP_005778.1 Q92685-1
ALG3NM_001006941.2 linkc.940G>A p.Val314Ile missense_variant Exon 8 of 9 NP_001006942.1 Q92685-2
ALG3NR_024533.1 linkn.1015G>A non_coding_transcript_exon_variant Exon 7 of 8
ALG3NR_024534.1 linkn.1078G>A non_coding_transcript_exon_variant Exon 8 of 9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ALG3ENST00000397676.8 linkc.1084G>A p.Val362Ile missense_variant Exon 8 of 9 1 NM_005787.6 ENSP00000380793.3 Q92685-1

Frequencies

GnomAD3 genomes
AF:
0.000795
AC:
121
AN:
152166
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.000576
Gnomad EAS
AF:
0.00557
Gnomad SAS
AF:
0.00145
Gnomad FIN
AF:
0.000472
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00103
Gnomad OTH
AF:
0.000959
GnomAD2 exomes
AF:
0.00121
AC:
300
AN:
248924
AF XY:
0.00115
show subpopulations
Gnomad AFR exome
AF:
0.000258
Gnomad AMR exome
AF:
0.000145
Gnomad ASJ exome
AF:
0.00139
Gnomad EAS exome
AF:
0.00512
Gnomad FIN exome
AF:
0.000328
Gnomad NFE exome
AF:
0.00140
Gnomad OTH exome
AF:
0.00182
GnomAD4 exome
AF:
0.00147
AC:
2142
AN:
1461526
Hom.:
3
Cov.:
32
AF XY:
0.00144
AC XY:
1050
AN XY:
727038
show subpopulations
African (AFR)
AF:
0.000179
AC:
6
AN:
33478
American (AMR)
AF:
0.000268
AC:
12
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.000727
AC:
19
AN:
26136
East Asian (EAS)
AF:
0.00547
AC:
217
AN:
39700
South Asian (SAS)
AF:
0.000290
AC:
25
AN:
86258
European-Finnish (FIN)
AF:
0.000507
AC:
27
AN:
53274
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00154
AC:
1716
AN:
1111820
Other (OTH)
AF:
0.00199
AC:
120
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
133
266
400
533
666
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
74
148
222
296
370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000795
AC:
121
AN:
152284
Hom.:
0
Cov.:
33
AF XY:
0.000712
AC XY:
53
AN XY:
74450
show subpopulations
African (AFR)
AF:
0.000120
AC:
5
AN:
41562
American (AMR)
AF:
0.0000654
AC:
1
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.000576
AC:
2
AN:
3472
East Asian (EAS)
AF:
0.00559
AC:
29
AN:
5190
South Asian (SAS)
AF:
0.00145
AC:
7
AN:
4828
European-Finnish (FIN)
AF:
0.000472
AC:
5
AN:
10604
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00103
AC:
70
AN:
68026
Other (OTH)
AF:
0.000949
AC:
2
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
6
12
18
24
30
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00124
Hom.:
2
Bravo
AF:
0.000827
TwinsUK
AF:
0.00270
AC:
10
ALSPAC
AF:
0.00104
AC:
4
ESP6500AA
AF:
0.00146
AC:
6
ESP6500EA
AF:
0.000595
AC:
5
ExAC
AF:
0.00121
AC:
147
Asia WGS
AF:
0.00404
AC:
14
AN:
3478
EpiCase
AF:
0.00153
EpiControl
AF:
0.00148

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:5Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:3
May 13, 2019
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; Has not been previously published in a patient, as pathogenic or benign, to our knowledge; This variant is associated with the following publications: (PMID: 30061496) -

Mar 01, 2018
CeGaT Center for Human Genetics Tuebingen
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 08, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

ALG3-congenital disorder of glycosylation Uncertain:2Benign:1
Jan 18, 2018
Baylor Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

Jan 11, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.098
BayesDel_addAF
Benign
-0.16
T
BayesDel_noAF
Uncertain
0.0
CADD
Uncertain
25
DANN
Uncertain
0.99
DEOGEN2
Benign
0.27
T;.;.
Eigen
Uncertain
0.58
Eigen_PC
Uncertain
0.61
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Pathogenic
0.98
D;D;D
M_CAP
Benign
0.040
D
MetaRNN
Benign
0.021
T;T;T
MetaSVM
Uncertain
0.23
D
MutationAssessor
Benign
1.9
L;.;.
PhyloP100
7.7
PrimateAI
Uncertain
0.72
T
PROVEAN
Benign
-0.31
N;N;N
REVEL
Uncertain
0.51
Sift
Benign
0.34
T;T;T
Sift4G
Benign
0.41
T;T;T
Polyphen
0.99
D;.;P
Vest4
0.64
MVP
0.84
MPC
0.36
ClinPred
0.020
T
GERP RS
5.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.1
Varity_R
0.14
gMVP
0.44
Mutation Taster
=27/73
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs186946267; hg19: chr3-183960671; COSMIC: COSV56612513; COSMIC: COSV56612513; API